Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53

Blood (2019) 134 (21): 1821–1831.

https://doi.org/10.1182/blood.2019001187

Published: 2019

Includes: Supplemental data

Journal Articles

B-cell prolymphocytic leukemia has 3 subsets

Neil E. Kay, Curtis A. Hanson

Blood (2019) 134 (21): 1777–1778.

https://doi.org/10.1182/blood.2019003046

Published: 2019

Journal Articles

The Diagnostic Value of Kappa/Lambda Ratios Determined By Flow Cytometric Analysis of Peripheral Blood and Bone Marrow Specimens in B-Cell Chronic Proliferative Disease

Aldair Sousa Paiva, PhD, Alessandra Suelen Jardim, Victor lima Soares, Hugo Diogenes De Oliveira Paiva, MD, Frank Bahia, MD, Valéria SF Sales, PhD, Marcos Dias Leão, PhD, Antonia Eduarda Martins Oliveira Elói Silva, João Pedro Andrade Lima, Geraldo Barroso Cavalcanti, Jr., PhD

Blood (2018) 132 (Supplement 1): 5431.

https://doi.org/10.1182/blood-2018-99-119868

Published: 2018

Journal Articles

Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYC and TP53 Abnormalities. on Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group

Blood (2018) 132 (Supplement 1): 943.

https://doi.org/10.1182/blood-2018-99-115085

Published: 2018

Journal Articles

Expression of the CD5 Molecule in Chronic Lymphocytic Leukemia

Aldair Paiva, MD, Gabriela VA Alves, PhD, Lenilton Silva Silveira, Jr., MD, Erica Aires Gil, MD, Rodolfo DA Soares, MD, Dany GKC Silva, Rodrigo Villar Freitas, MD, Frank Bahia, MD, Marcelo Rocha Barbosa, MD, Geraldo Barroso Cavalcanti, Jr., PhD

Blood (2017) 130 (Supplement 1): 5322.

https://doi.org/10.1182/blood.V130.Suppl_1.5322.5322

Published: 2017

Journal Articles

Clinical Utility of Flow Cytometry Immunophenotyping and Hematological Profile in Chronic Lymphoproliferative Disorders

Aldair Paiva, MD, Gabriela VA Alves, PhD, Valéria SF Sales, PhD, Alexandra SJ Silva, Dany GKC Silva, Enildo Alves, MD, Frank Bahia, MD, Rodrigo Villar Freitas, MD, Hugo Diogenes De Oliveira Paiva, MD, Geraldo Barroso Cavalcanti, Jr., PhD

Blood (2017) 130 (Supplement 1): 5326.

https://doi.org/10.1182/blood.V130.Suppl_1.5326.5326

Published: 2017

Journal Articles

B-Cell Prolymphocytic Leukemia, a Rare Lymphoproliferative Disorder: Analysis of 35 Cases, a Study on Behalf of the French Innovative Leukemia Organization (FILO)

Caroline Algrin, Elise Chapiro, Justine Saviellis, Anne Quinquenel, Anne-Sophie Michallet, MD PhD, David Ghez, MD PhD, Pierre Feugier, MD, Annie Brion, Cecile Tomowiak, MD, Luc-Matthieu Fornecker, Remy Gressin, MD, Laurent Sutton, MD, Karim Maloum, Catherine Settegrana, Lucile Baseggio, MD, Quentin Vincent, Florence Nguyen-Khac, MD PhD, Véronique Leblond

Blood (2017) 130 (Supplement 1): 4310.

https://doi.org/10.1182/blood.V130.Suppl_1.4310.4310

Published: 2017

Journal Articles

Idelalisib-Rituximab Results in Considerable Toxicity but Induces Durable Clinical Remissions in Patients with TP53 Disrupted B Cell Prolymphocytic Leukemia

Toby A. Eyre, MBBChir, MRCP, Christopher P. Fox, MBChB, PhD, Ali Boden, MRCP, Adrian Bloor, Moez Dungawalla, Paneesha Shankara, Richard Went, Anna Schuh, MD PhD

Blood (2017) 130 (Supplement 1): 4068.

https://doi.org/10.1182/blood.V130.Suppl_1.4068.4068

Published: 2017

Journal Articles

Deletion 7q Is Associated with KLF2 and NOTCH2 Mutations and Is Strongly Correlated with Splenic Marginal Zone Lymphoma but Also Found in Lymphoplasmacytic Lymphoma and Hairy Cell Leukemia Variant

Alexander Höllein, MD, Anna Stengel, PhD, Manja Meggendorfer, PhD, Annette Fasan, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2017) 130 (Supplement 1): 1465.

https://doi.org/10.1182/blood.V130.Suppl_1.1465.1465

Published: 2017

Journal Articles

Atypical Chronic Lymphocytic Leukemia with CD200 Expression Shares Similar Outcomes to Classical Chronic Lymphocytic Leukemia

Zoe Mongeau-Marceau, MD, Sandra Cohen, MD, Luigina Mollica, MD PhD, Richard LeBlanc, MD, Bernard Fortin, MD FRCPC, Rafik Terra, PhD, Isabelle Fleury, MD MSc, FRCPC

Blood (2016) 128 (22): 5572.

https://doi.org/10.1182/blood.V128.22.5572.5572

Published: 2016

Journal Articles

Differential Diagnosis of Lymphoid Enhancer-Binding Factor 1 Between Chronic Lymphocytic Leukemia and Other B-Cell Chronic Lymphoproliferative Disorders

Lei Fan, MD, PhD, Tingmei Shen, Rong Wang, Yi Miao, Yujie Wu, Hui Yang, Li Wang, Wei Xu, Jianyong Li, MD PhD

Blood (2015) 126 (23): 4148.

https://doi.org/10.1182/blood.V126.23.4148.4148

Published: 2015

Journal Articles

B-cell prolymphocytic leukemia: a specific subgroup of mantle cell lymphoma

Vincent H. J. van der Velden, Patricia G. Hoogeveen, Dick de Ridder, Magdalena Schindler-van der Struijk, Menno C. van Zelm, Mathijs Sanders, Dennis Karsch, H. Berna Beverloo, King Lam, Alberto Orfao, Pieternella J. Lugtenburg, Sebastian Böttcher, Jacques J. M. van Dongen, Anton W. Langerak, Mies Kappers-Klunne, Kirsten van Lom

Blood (2014) 124 (3): 412–419.

https://doi.org/10.1182/blood-2013-10-533869

Published: 2014

Includes: Supplemental data

Journal Articles

The Spectrum Of Cold Agglutinin Disease At The Era Of Rituximab: A Retrospective Study On 48 Patients

Mathilde Lamarque, MD, Véronique Leblond, MD, PhD, Bruno R. Varet, MD, Sylvain Choquet, MD, Jean Paul Vernant, MD, Richard Delarue, MD, Bertrand Godeau, MD, Olivier Hermine, MD, PhD, Marc Michel, IV

Blood (2013) 122 (21): 2193.

https://doi.org/10.1182/blood.V122.21.2193.2193

Published: 2013

Journal Articles

Update On The Safety and Efficacy Of The Pan Class I PI3K Inhibitor SAR245408 (XL147) In Chronic Lymphocytic Leukemia and Non-Hodgkin’s Lymphoma Patients

Jennifer R. Brown, MD, PhD, Matthew S. Davids, MD, Jordi Rodon, MD, Pau Abrisqueta, MD, Coumaran Egile, PhD, Rodrigo Ruiz-Soto, MD, MSc, Farrukh Awan, MD, MS

Blood (2013) 122 (21): 4170.

https://doi.org/10.1182/blood.V122.21.4170.4170

Published: 2013

Journal Articles

Smudge cells following treatment with pentostatin in a patient with B-cell prolymphocytic leukemia

Hyun Don Yun, Edmund K. Waller

Blood (2013) 122 (4): 474.

https://doi.org/10.1182/blood-2013-02-481697

Published: 2013

Journal Articles

Phase I Trial of SAR245408 (S08), a Pan-Phosphatidylinositol 3 Kinase (PI3K) Inhibitor, in Patients with Chronic Lymphocytic Leukemia (CLL) and Lymphoma

Jennifer R Brown, MD, PhD, Matthew S. Davids, MD, Jordi Rodon, MD, Pau Abrisqueta, MD, Arthur P. DeCillis, MD, MS, Kevin Rockich, Coumaran Egile, Adrianne Kelly, MD, Yi Xu, Joanne Lager, MD, Farrukh T Awan, MD, MS

Blood (2011) 118 (21): 2683.

https://doi.org/10.1182/blood.V118.21.2683.2683

Published: 2011

Journal Articles

Stimulation of B-Cell Mature Malignancies with the CpG-Oligonucleotide DSP30 and Interleukin-2 for Improved Detection of Chromosome Abnormalities.

Aurelia Meloni-Ehrig, Jeanne Meck, Nicole Christacos, JoAnn Kelly, Ludmila Matyakhina, Steven Schonberg, Bruce Gorman, Ramesh Babu, Patricia Stone, Steven Gersen, Alma Ganezer, Tracy Giacobbe, Lisa Brailey, Connie Novick, Jennifer Otani, Nasrin Shahbazi, Calvin Croft, Rafael Perez, Philip Mowrey

Blood (2009) 114 (22): 1955.

https://doi.org/10.1182/blood.V114.22.1955.1955

Published: 2009

Journal Articles

transCGH: Rapid Identification and High-Resolution Mapping of Balanced IgH Translocations in Archival DNA Using Custom Oligonucleotide Arrays.

Harvey A. Greisman, MD, PhD, Hye Son Yi, Noah G. Hoffman, M.D., Ph.D.

Blood (2007) 110 (11): 459.

https://doi.org/10.1182/blood.V110.11.459.459

Published: 2007

Journal Articles

B-Cell Prolymphocytic Leukemia (B-PLL) and Chronic Lymphocytic Leukemia (CLL) Express Distinct Genomic Profiles.

Ilaria Del Giudice, MD, Nnenna Osuji, MRCPath, Tim Dexter, PhD, Estella Matutes, FRCPath, Vasantha Brito-Babapulle, PhD, Nilima Parry-Jones, MD, Daniel Catovsky, FRCPath

Blood (2005) 106 (11): 4372.

https://doi.org/10.1182/blood.V106.11.4372.4372

Published: 2005

Journal Articles

B- Prolymphocytic Leukemia Shows Heterogeneous IgVH Mutational Status and Expression of ZAP-70 and CD38.

Ilaria Del Giudice, Zadie Davis, Nnenna Osuji, Nilima Parry-Jones, Estella Matutes, Vasantha Brito-Babapulle, Andrew Wotherspoon, David Oscier, Daniel Catovsky

Blood (2004) 104 (11): 2004.

https://doi.org/10.1182/blood.V104.11.2004.2004

Published: 2004

NARROW

Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53

B-cell prolymphocytic leukemia has 3 subsets

The Diagnostic Value of Kappa/Lambda Ratios Determined By Flow Cytometric Analysis of Peripheral Blood and Bone Marrow Specimens in B-Cell Chronic Proliferative Disease

Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYC and TP53 Abnormalities. on Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group

Expression of the CD5 Molecule in Chronic Lymphocytic Leukemia

Clinical Utility of Flow Cytometry Immunophenotyping and Hematological Profile in Chronic Lymphoproliferative Disorders

B-Cell Prolymphocytic Leukemia, a Rare Lymphoproliferative Disorder: Analysis of 35 Cases, a Study on Behalf of the French Innovative Leukemia Organization (FILO)

Idelalisib-Rituximab Results in Considerable Toxicity but Induces Durable Clinical Remissions in Patients with TP53 Disrupted B Cell Prolymphocytic Leukemia

Deletion 7q Is Associated with KLF2 and NOTCH2 Mutations and Is Strongly Correlated with Splenic Marginal Zone Lymphoma but Also Found in Lymphoplasmacytic Lymphoma and Hairy Cell Leukemia Variant

Atypical Chronic Lymphocytic Leukemia with CD200 Expression Shares Similar Outcomes to Classical Chronic Lymphocytic Leukemia

Differential Diagnosis of Lymphoid Enhancer-Binding Factor 1 Between Chronic Lymphocytic Leukemia and Other B-Cell Chronic Lymphoproliferative Disorders

B-cell prolymphocytic leukemia: a specific subgroup of mantle cell lymphoma

The Spectrum Of Cold Agglutinin Disease At The Era Of Rituximab: A Retrospective Study On 48 Patients

Update On The Safety and Efficacy Of The Pan Class I PI3K Inhibitor SAR245408 (XL147) In Chronic Lymphocytic Leukemia and Non-Hodgkin’s Lymphoma Patients

Smudge cells following treatment with pentostatin in a patient with B-cell prolymphocytic leukemia

Phase I Trial of SAR245408 (S08), a Pan-Phosphatidylinositol 3 Kinase (PI3K) Inhibitor, in Patients with Chronic Lymphocytic Leukemia (CLL) and Lymphoma

Stimulation of B-Cell Mature Malignancies with the CpG-Oligonucleotide DSP30 and Interleukin-2 for Improved Detection of Chromosome Abnormalities.

transCGH: Rapid Identification and High-Resolution Mapping of Balanced IgH Translocations in Archival DNA Using Custom Oligonucleotide Arrays.

B-Cell Prolymphocytic Leukemia (B-PLL) and Chronic Lymphocytic Leukemia (CLL) Express Distinct Genomic Profiles.

B- Prolymphocytic Leukemia Shows Heterogeneous IgVH Mutational Status and Expression of ZAP-70 and CD38.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only